<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05628246</url>
  </required_header>
  <id_info>
    <org_study_id>Si 310/2022</org_study_id>
    <nct_id>NCT05628246</nct_id>
  </id_info>
  <brief_title>Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient</brief_title>
  <official_title>Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient: A Prospective Non-randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cancer is the second leading cause of death worldwide, with approximately 18.1 million new&#xD;
      cases and 9.6 million deaths reported in 2018. Cancer-related pain is experienced by 50-70%&#xD;
      of patients, with a higher prevalence at advanced disease stages (66.4%). Since the&#xD;
      development of WHO's cancer pain guidelines, several studies have reported good relief of&#xD;
      symptoms and suffering for a majority of patients. Recent reports suggest that up to 50% of&#xD;
      patients still report insufficient pain control. Patients with cancer often present with&#xD;
      multiple symptoms and functional decline. Evidence supports multidisciplinary approaches to&#xD;
      address symptoms and suffering, including early palliative care referral&#xD;
&#xD;
      From review literatures we found that the telemedicine group had significantly higher quality&#xD;
      of life than the usual care group. In addition, the telemedicine group had lower anxiety and&#xD;
      depression scores than the usual care group.&#xD;
&#xD;
      Therefore, we will conduct the non-randomized controlled study of using telemedicine&#xD;
      comparing to conventional in-person at OPD in hospitalized cancer pain patients.&#xD;
&#xD;
      The purpose of this study is to assess the pain interference by using the Brief Pain&#xD;
      Inventory (BPI) and to compare between the in-person group and the telemedicine group. To&#xD;
      assess the cost-effectiveness of telemedicine for reducing symptoms associated with cancer&#xD;
      and its treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The pain interference will be assessed and compared using Brief Pain Inventory from 0-70&#xD;
      between In-person group and telemedicine group at 1 month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2023</start_date>
  <completion_date type="Anticipated">July 17, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 17, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain interference</measure>
    <time_frame>at 1 month</time_frame>
    <description>The pain interference will be assessed and compared using Brief Pain Inventory from 0-70 between In-person group and telemedicine group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL)</measure>
    <time_frame>at 1 month</time_frame>
    <description>The quality of life will be assessed and compared using EuroQoL 5D5L between In-person group and telemedicine group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>at 1 month, 2 months and 3 months</time_frame>
    <description>The pain reduction will be assessed and compared using numerical rating (NRS) from 0-10; 0 designating &quot;no pain&quot; and 10 designating &quot; worst possible pain&quot; scale between In-person group and telemedicine group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">206</enrollment>
  <condition>Pain, Chronic</condition>
  <condition>Cancer Pain</condition>
  <arm_group>
    <arm_group_label>In-person</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Face to face at OPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemedicine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Telemedicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telemedicine</intervention_name>
    <description>Telemedicine</description>
    <arm_group_label>Telemedicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>In-person</intervention_name>
    <description>In-person</description>
    <arm_group_label>In-person</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age older than 18 years old&#xD;
&#xD;
          -  Cancer patients who new visit as out patient at pain clinic, Siriraj hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cannot read and write&#xD;
&#xD;
          -  Confusion&#xD;
&#xD;
          -  Unable to use the 0-10 Numerical Rating Scale (NRS) to rate pain intensity.&#xD;
&#xD;
          -  Unstable clinical presentation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suratsawadee Wangnamthip, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suratsawadee Wangnamthip, M.D.</last_name>
    <phone>+66-81-926-1509</phone>
    <email>suratsawadee.wan@mahidol.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of medicine Siriraj Hospital Mahidol University</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suratsawadee Wangnamthip, M.D.</last_name>
      <phone>+66-81-926-1509</phone>
      <email>suratsawadee.wan@mahidol.ac.th</email>
    </contact>
    <investigator>
      <last_name>Suratsawadee Wangnamthip, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>Pang L, Liu Z, Lin S, Liu Z, Liu H, Mai Z, Liu Z, Chen C, Zhao Q. The effects of telemedicine on the quality of life of patients with lung cancer: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2020 Oct 7;11:2040622320961597. doi: 10.1177/2040622320961597. eCollection 2020.</citation>
    <PMID>33101621</PMID>
  </results_reference>
  <results_reference>
    <citation>Wangnamthip S, Panchoowong S, Donado C, Lobo K, Phankhongsap P, Sriveerachai P, Euasobhon P, Rushatamukayanunt P, Mandee S, Zinboonyahgoon N, Berde CB. The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: A Prospective Observational Study. Pain Res Manag. 2021 Jul 20;2021:5599023. doi: 10.1155/2021/5599023. eCollection 2021.</citation>
    <PMID>34336068</PMID>
  </results_reference>
  <results_reference>
    <citation>Chaudakshetrin P. Validation of the Thai Version of Brief Pain Inventory (BPI-T) in cancer patients. J Med Assoc Thai. 2009 Jan;92(1):34-40.</citation>
    <PMID>19260241</PMID>
  </results_reference>
  <results_reference>
    <citation>Pattanaphesaj J, Thavorncharoensap M, Ramos-Goni JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L Valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):551-558. doi: 10.1080/14737167.2018.1494574. Epub 2018 Jul 6.</citation>
    <PMID>29958008</PMID>
  </results_reference>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>November 15, 2022</study_first_submitted>
  <study_first_submitted_qc>November 24, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2022</study_first_posted>
  <last_update_submitted>January 26, 2023</last_update_submitted>
  <last_update_submitted_qc>January 26, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

